Compare MOH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOH | RGEN |
|---|---|---|
| Founded | 1980 | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.0B |
| IPO Year | 2002 | 1995 |
| Metric | MOH | RGEN |
|---|---|---|
| Price | $197.37 | $179.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $167.00 | ★ $167.67 |
| AVG Volume (30 Days) | 437.6K | ★ 854.3K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 1.46 | 0.24 |
| Revenue | ★ $45,426,000,000.00 | $141,236,000.00 |
| Revenue This Year | $2.40 | $14.30 |
| Revenue Next Year | $5.18 | $14.52 |
| P/E Ratio | ★ $137.99 | $735.50 |
| Revenue Growth | 11.75 | ★ 35.10 |
| 52 Week Low | $121.06 | $100.99 |
| 52 Week High | $244.89 | $188.73 |
| Indicator | MOH | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 61.83 |
| Support Level | $196.50 | $158.15 |
| Resistance Level | $204.11 | $188.73 |
| Average True Range (ATR) | 6.39 | 6.66 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 35.10 | 86.49 |
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.